Free Trial

Recursion Pharmaceuticals (RXRX) Insider Trading & Ownership

Recursion Pharmaceuticals logo
$5.26 +0.05 (+0.96%)
Closing price 03:58 PM Eastern
Extended Trading
$5.25 -0.01 (-0.27%)
As of 04:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recursion Pharmaceuticals (NASDAQ:RXRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.43%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$2.31M
Get RXRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Recursion Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RXRX Insider Buying and Selling by Quarter

Recursion Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/13/2024Michael SecoraCFOSell15,000$7.66$114,900.00  
11/12/2024Blake BorgesonDirectorSell11,447$7.64$87,455.08  
10/29/2024Blake BorgesonDirectorSell11,447$6.72$76,923.84  
10/24/2024Tina MarriottCOOSell6,000$6.31$37,860.00  
10/15/2024Blake BorgesonDirectorSell11,447$6.67$76,351.49  
10/8/2024Michael SecoraCFOSell15,000$6.32$94,800.00  
10/2/2024Christopher GibsonCEOSell20,000$6.16$123,200.00  
10/1/2024Blake BorgesonDirectorSell11,447$6.22$71,200.34  
9/26/2024Tina MarriottCOOSell6,000$7.00$42,000.00  
9/17/2024Blake BorgesonDirectorSell11,447$6.84$78,297.48  
9/10/2024Michael SecoraCFOSell15,000$6.17$92,550.00  
9/4/2024Christopher GibsonCEOSell20,000$6.04$120,800.00  
9/3/2024Blake BorgesonDirectorSell11,447$6.27$71,772.69  
8/29/2024Tina MarriottCOOSell6,000$7.56$45,360.00  
8/20/2024Blake BorgesonDirectorSell11,447$7.12$81,502.64  
8/13/2024Michael SecoraCFOSell15,000$6.35$95,250.00  
8/7/2024Christopher GibsonCEOSell30,000$7.10$213,000.00  
8/6/2024Blake BorgesonDirectorSell11,447$6.82$78,068.54  
7/25/2024Tina MarriottCOOSell6,000$8.13$48,780.00  
7/23/2024Blake BorgesonDirectorSell11,447$8.48$97,070.56  
7/10/2024Christopher GibsonCEOSell50,000$7.48$374,000.00  
7/9/2024Blake BorgesonDirectorSell11,447$7.32$83,792.04  
7/9/2024Michael SecoraCFOSell15,000$7.32$109,800.00  
(Data available from 1/1/2013 forward)

RXRX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Recursion Pharmaceuticals includes Blake Borgeson, Christopher Gibson, Dean Y Li, Michael Secora, Mubadala Investment Co Pjsc, Shafique Virani, Terry-Ann Burrell, Tina Marriott, Tina Marriott Larson, and Zavain Dar. Learn more on insiders at RXRX.

8.43% of Recursion Pharmaceuticals stock is owned by insiders. Learn more on RXRX's insider holdings.

The following insiders have sold RXRX shares in the last 24 months: Blake Borgeson ($3,782,145.92), Christopher Gibson ($6,199,601.32), Dean Y Li ($396,140.00), Michael Secora ($2,905,879.92), Shafique Virani ($1,562,300.00), Terry-Ann Burrell ($104,182.25), Tina Marriott ($471,730.00), Tina Marriott Larson ($278,070.00), and Zavain Dar ($181,269.00).

Insiders have sold a total of 1,761,714 Recursion Pharmaceuticals shares in the last 24 months for a total of $15,881,318.41 sold.



This page (NASDAQ:RXRX) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners